BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 25772664)

  • 1. [Current treatment and epidemiology of Clostridium difficile infections].
    Dinh A; Bouchand F; Le Monnier A
    Rev Med Interne; 2015 Sep; 36(9):596-602. PubMed ID: 25772664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for Clostridium difficile infections in Baranya County, Southern Hungary.
    Vigvári S; Sipos D; Kappéter Á; Feiszt Z; Kovács B; Péterfi Z
    Acta Microbiol Immunol Hung; 2018 Jun; 65(2):183-192. PubMed ID: 29651860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of adult Clostridium difficile digestive contaminations: a literature review.
    Mathias F; Curti C; Montana M; Bornet C; Vanelle P
    Eur J Clin Microbiol Infect Dis; 2019 Feb; 38(2):209-231. PubMed ID: 30498879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clostridium difficile infections: emerging epidemiology and new treatments.
    Cohen MB
    J Pediatr Gastroenterol Nutr; 2009 Apr; 48 Suppl 2():S63-5. PubMed ID: 19300129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Best strategies in recurrent or persistent Clostridium difficile infection.
    Cocanour CS
    Surg Infect (Larchmt); 2011 Jun; 12(3):235-9. PubMed ID: 21767157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clostridium difficile infection: A brief update on emerging therapies.
    Goldberg EJ; Bhalodia S; Jacob S; Patel H; Trinh KV; Varghese B; Yang J; Young SR; Raffa RB
    Am J Health Syst Pharm; 2015 Jun; 72(12):1007-12. PubMed ID: 26025991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update of treatment algorithms for Clostridium difficile infection.
    Ooijevaar RE; van Beurden YH; Terveer EM; Goorhuis A; Bauer MP; Keller JJ; Mulder CJJ; Kuijper EJ
    Clin Microbiol Infect; 2018 May; 24(5):452-462. PubMed ID: 29309934
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Asempa TE; Nicolau DP
    Clin Interv Aging; 2017; 12():1799-1809. PubMed ID: 29123385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clostridium difficile infection: an update on epidemiology, risk factors, and therapeutic options.
    Lo Vecchio A; Zacur GM
    Curr Opin Gastroenterol; 2012 Jan; 28(1):1-9. PubMed ID: 22134217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges and opportunities in the management of Clostridium difficile infection.
    DuPont HL
    Expert Rev Gastroenterol Hepatol; 2014 Nov; 8(8):863-74. PubMed ID: 25012255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and management of Clostridium difficile infection.
    Korman TM
    Semin Respir Crit Care Med; 2015 Feb; 36(1):31-43. PubMed ID: 25643269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New and emerging therapies in treatment of Clostridium difficile infection.
    Goyal H; Perisetti A; Rehman MR; Singla U
    Eur J Gastroenterol Hepatol; 2018 Jun; 30(6):589-597. PubMed ID: 29521664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clostridium difficile infection: update on diagnosis, epidemiology, and treatment strategies.
    To KB; Napolitano LM
    Surg Infect (Larchmt); 2014 Oct; 15(5):490-502. PubMed ID: 25314344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A network meta-analysis of randomized controlled trials exploring the role of fecal microbiota transplantation in recurrent
    Rokkas T; Gisbert JP; Gasbarrini A; Hold GL; Tilg H; Malfertheiner P; Megraud F; O'Morain C
    United European Gastroenterol J; 2019 Oct; 7(8):1051-1063. PubMed ID: 31662862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clostridium difficile infection: current, forgotten and emerging treatment options.
    Drekonja DM
    J Comp Eff Res; 2014 Sep; 3(5):547-57. PubMed ID: 25350805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring ways to improve CDI outcomes.
    Galpérine T; Guery B;
    Med Mal Infect; 2018 Feb; 48(1):10-17. PubMed ID: 29336930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Recurrent Clostridium difficile infections: the importance of the intestinal microbiota].
    Zanella Terrier MC; Frossard JL; Simonet ML
    Rev Med Suisse; 2013 Oct; 9(402):1898, 1900-4. PubMed ID: 24298714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Case series of Clostridium difficile NAP1/027/BI with novels treatments].
    Pérez-Topete SE; Miranda-Aquino T; Ayala-Gaytan JJ
    Rev Med Inst Mex Seguro Soc; 2017; 55(5):654-659. PubMed ID: 29193949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current advances related to Clostridium difficile infection.
    Kim YG; Jang BI
    Indian J Med Res; 2015 Feb; 141(2):172-4. PubMed ID: 25900952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clostridium difficile Infection and Fecal Microbiota Transplant.
    Liubakka A; Vaughn BP
    AACN Adv Crit Care; 2016 Jul; 27(3):324-337. PubMed ID: 27959316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.